
Feature|Videos|July 7, 2025
Harmonizing the Payer Perspective with Real-World Evidence
Expert panelists emphasize the importance of trusted data sources, strong payer partnerships, economic incentives, and AI-driven insights to address skepticism and support broader reimbursement and access strategies as payers balance real-world evidence with head-to-head clinical trials in their decision-making.
Advertisement
Episodes in this series

The trust gap between real-world evidence (RWE)/data and randomized controlled trials is growing. This episode examines when each evidence type is appropriate, how to reduce perceived bias in RWE, and how payer context varies by geography and structure. Insights from academic and payer partnerships show how joint research can establish credibility and unlock market access.
Key discussion topics include:
- Strategies for reducing payer skepticism about real-world data.
- The influence of health system structure on RWE acceptance.
- Use cases for RWE in confirmatory versus primary evidence roles.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
How is Boehringer Ingelheim's Deliberate GLP-1 Strategy Different From Competitors?
2
Evolving Beyond Launch Postmortems to Real-Time Optimization
3
Biogen Enters $1 Billion Agreement to Acquire RayThera Inc.
4
Expanding the Vaccine Landscape with New Technologies: Q&A with Silvia Taylor
5





